Skip Navigation
Skip to contents



13 results

Tumor Lysis Syndrome in a Patient with Metastatic Colon Cancer after Treatment with 5-Fluorouracil/Leucovorin and Oxaliplatin: Case Report and Literature Review

Kim HD, Ha KS, Woo IS, Jung YH, Han CW, Kim TJ

  • Cancer Res Treat.
  • 2014 Apr;46(2):204-207.
Development of tumor lysis syndrome (TLS) may occur after chemotherapy or spontaneously in bulky or rapidly growing tumors. This syndrome is frequent but preventable in patients with hematologic malignancies. TLS...
Intra-tumoral Metastatic Double Primary Carcinoma: Synchronous Metastatic Tumor in Lung from Breast and Thyroid Carcinoma

Park LC, Jeong JY, Ji JH, Park S, Ahn JS, Im YH, Park YH

  • Cancer Res Treat.
  • 2014 Apr;46(2):200-203.
Cases of phenotypic heterogeneity of cells within tumors have recently been reported. Here, we report on a patient with characteristic intra-tumor double primary metastases in the lung. This patient was...
Case Series of Different Onset of Skin Metastasis According to the Breast Cancer Subtypes

Cho J, Park Y, Lee JC, Jung WJ, Lee S

  • Cancer Res Treat.
  • 2014 Apr;46(2):194-199.
We report on five cases of skin metastasis according to the breast cancer (BC) subtype. Two cases of HER2 positive BC showed only skin metastasis after immediate postoperative period and...
Preclinical Efficacy Testing for Stomach and Liver Cancers

Park JW, Baek NS, Lee SC, Oh SJ, Jang SH, Kim IH, Kim DY, Kim HK

  • Cancer Res Treat.
  • 2014 Apr;46(2):186-193.
PURPOSE: Hollow fiber assays offer an early in vivo method of anticancer drug screening. The assays have been optimized for human cancers originating from the lung, breast, colon, ovary, and...
Diagnostic Value of Circulating Extracellular miR-134, miR-185, and miR-22 Levels in Lung Adenocarcinoma-Associated Malignant Pleural Effusion

Shin YM, Yun J, Lee OJ, Han HS, Lim SN, An JY, Lee KH, Lee KM, Choe KH

  • Cancer Res Treat.
  • 2014 Apr;46(2):178-185.
PURPOSE: The accurate and timely diagnosis of malignant pleural effusion (MPE) in lung cancer patients is important because MPE has a poor prognosis and is classified as stage IV disease....
Modified MVAC as a Second-Line Treatment for Patients with Metastatic Urothelial Carcinoma after Failure of Gemcitabine and Cisplatin Treatment

Lee JH, Kang SG, Kim ST, Kang SH, Choi IK, Park YJ, Oh SC, Sung DJ, Seo JH, Cheon J, Shin SW, Kim YH, Kim JS, Park KH

  • Cancer Res Treat.
  • 2014 Apr;46(2):172-177.
PURPOSE: There is no established standard second-line chemotherapy for patients with advanced or metastatic urothelial carcinoma (UC) who failed gemcitabine and cisplatin (GC) chemotherapy. This study was conducted in order...
Metabolic Burden Measured by 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Is a Prognostic Factor in Patients with Small Cell Lung Cancer

Kim MH, Lee JS, Mok JH, Lee K, Kim KU, Park HK, Kim SJ, Lee MK

  • Cancer Res Treat.
  • 2014 Apr;46(2):165-171.
PURPOSE: Evidence regarding the usefulness of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in predicting the prognosis of non-small cell lung cancer is increasing. However, data on small cell lung...
Clinical Outcomes of Local Excision Following Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer

Lee NK, Kim DY, Kim SY, Oh JH, Park W, Choi DH, Nam TK, Lee KJ

  • Cancer Res Treat.
  • 2014 Apr;46(2):158-164.
PURPOSE: To evaluate the treatment outcomes of local excision following preoperative chemoradiotherapy in patients with locally advanced rectal cancer who have not undergone radical surgery for any reason. MATERIALS AND METHODS:...
Impact on Loco-regional Control of Radiochemotherapeutic Sequence and Time to Initiation of Adjuvant Treatment in Stage II/III Rectal Cancer Patients Treated with Postoperative Concurrent Radiochemotherapy

Kim H, Chie EK, Ahn YC, Kim K, Park W, Yoon WS, Huh SJ, Ha SW

  • Cancer Res Treat.
  • 2014 Apr;46(2):148-157.
PURPOSE: This study was designed to evaluate the impact of radiochemotherapeutic sequence and time to initiation of adjuvant treatment on loco-regional control for resected stage II and III rectal cancer. MATERIALS...
Clinical Features and Treatment of Collecting Duct Carcinoma of the Kidney from the Korean Cancer Study Group Genitourinary and Gynecology Cancer Committee

Kwon KA, Oh SY, Kim HY, Kim HS, Lee HY, Kim TM, Lim HY, Lee NR, Lee HJ, Hong SH, Rha SY

  • Cancer Res Treat.
  • 2014 Apr;46(2):141-147.
PURPOSE: Collecting duct carcinoma (CDC) of the kidney is an aggressive disease with a poor prognosis, accountings for less than 1% of all renal cancers. To date, no standard therapy...
A Nationwide Survey of Knowledge of and Compliance with Cancer Pain Management Guidelines by Korean Physicians

Kim DY, Ahn JS, Lee KH, Kim YC, Lee J, Kim SY

  • Cancer Res Treat.
  • 2014 Apr;46(2):131-140.
PURPOSE: Although cancer pain is prevalent, under-treatment still remains a problem. Knowledge of and compliance with guidelines for management of cancer pain were analyzed for exploration of physician-related barriers to...
Prediction of Cancer Incidence and Mortality in Korea, 2014

Jung KW, Won YJ, Kong HJ, Oh CM, Lee DH, Lee JS

  • Cancer Res Treat.
  • 2014 Apr;46(2):124-130.
PURPOSE: We studied and reported on cancer incidence and mortality rates as projected for the year 2014 in order to estimate Korea's current cancer burden. MATERIALS AND METHODS: Cancer incidence data...
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2011

Jung KW, Won YJ, Kong HJ, Oh CM, Lee DH, Lee JS

  • Cancer Res Treat.
  • 2014 Apr;46(2):109-123.
PURPOSE: This study aimed to report nationwide cancer statistics in Korea, including incidence, mortality, survival, and prevalence, and their trends. MATERIALS AND METHODS: Incidence data from 1993 to 2011 were obtained...

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: